Literature DB >> 7240210

Regulation of acetylcholinesterase activity by nerve growth factor. Role of transcription and dissociation from effects on proliferation and neurite outgrowth.

L A Greene, A Rukenstein.   

Abstract

Studies are elaborated on regulation of acetylcholinesterase activity by nerve growth factor (NGF) in cultures of clonal PC12 pheochromocytoma cells. Acetylcholinesterase specific activity in these cultures is maximally and half-maximally increased by NGF concentrations of approximately 1-1.5 and 0.5 nM, respectively. These increases are blocked by antiserum to NGF and are neither mimicked nor significantly altered by epidermal growth factor (1-1000 ng/ml), dexamethasone (10 microM), or dibutyryl cAMP (1 mM). The action of NGF on acetylcholinesterase activity is abolished by low concentrations of the inhibitors of RNA synthesis, camptothecin and actinomycin D. Such findings indicate a transcriptional requirement for this effect of NGF. A series of PC12 variants were employed that in serum-containing medium do not show normal PC12 responses to NGF such as cessation of proliferation and neurite outgrowth. Each of the variants exhibited NGF-dependent increases in acetylcholinesterase specific activity. This suggests that the effects of NGF on regulation of acetylcholinesterase activity can be dissociated from the effects of the factor on neurite outgrowth and proliferation, and that NGF may therefore work via parallel or branching pathways.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240210

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  EGF-induced sustained tyrosine phosphorylation and decreased rate of down-regulation of EGF receptor in PC12h-R cells which show neuronal differentiation in response to EGF.

Authors:  M Yamada; T Ikeuchi; S Aimoto; H Hatanaka
Journal:  Neurochem Res       Date:  1996-07       Impact factor: 3.996

2.  Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6.

Authors:  T Satoh; S Nakamura; T Taga; T Matsuda; T Hirano; T Kishimoto; Y Kaziro
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

3.  Hypertrophy of pheochromocytoma cells treated with nerve growth factor and activators of adenylate cyclase.

Authors:  A S Tischler; H Mobtaker; P W Kwan; W J Jason; R A DeLellis; H J Wolfe
Journal:  Cell Tissue Res       Date:  1987-07       Impact factor: 5.249

4.  Immunocytochemical study of PC12 cells grafted to the brain of immature rats.

Authors:  C B Jaeger
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

5.  Endogenous butyrylcholinesterase in SV40 transformed cell lines: COS-1, COS-7, MRC-5 SV40, and WI-38 VA13.

Authors:  M Kris; O Jbilo; C F Bartels; P Masson; S Rhode; O Lockridge
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-10       Impact factor: 2.416

6.  Characterization of multiple exon 1 variants in mammalian HuD mRNA and neuron-specific transcriptional control via neurogenin 2.

Authors:  Lucas M Bronicki; Guy Bélanger; Bernard J Jasmin
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

7.  Association of a purine-analogue-sensitive protein kinase activity with p75 nerve growth factor receptors.

Authors:  C Volonté; A H Ross; L A Greene
Journal:  Mol Biol Cell       Date:  1993-01       Impact factor: 4.138

8.  Interleukin-1β enhances neuronal vulnerability to proNGF-mediated apoptosis by increasing surface expression of p75(NTR) and sortillin.

Authors:  S Choi; W J Friedman
Journal:  Neuroscience       Date:  2013-11-06       Impact factor: 3.590

9.  Acetylcholinesterase gene expression in axotomized rat facial motoneurons is differentially regulated by neurotrophins: correlation with trkB and trkC mRNA levels and isoforms.

Authors:  K J Fernandes; N R Kobayashi; B J Jasmin; W Tetzlaff
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

10.  Short-latency local actions of nerve growth factor at the growth cone.

Authors:  P J Seeley; L A Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.